Since the overexpression of the AhR/NF-κB signaling pathway is associated with oxidative stress and endothelial dysfunction [26], further studies investigating the treatment target of AhR are warranted in patients with LTBI. The gene discussed is NFKB1; the disease is endothelial dysfunction.